Simone Lasagni - Publications

The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment.

Journal: Cancers

Published: August 26, 2024

Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex.

Journal: Biomedicines

Published: May 21, 2024

The tumor microenvironment of VETC+ hepatocellular carcinoma is enriched of immunosuppressive TAMs spatially close to endothelial cells.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 06, 2024

Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids.

Journal: Biomedicines

Published: December 02, 2023

GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study.

Journal: Hepatology communications

Published: July 19, 2023

Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy.

Journal: Emerging infectious diseases

Published: May 30, 2023

Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: July 21, 2022

Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation.

Journal: Frontiers in oncology

Published: June 03, 2022

Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target.

Journal: The American journal of pathology

Published: May 19, 2022

Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma.

Journal: Oncology letters

Published: April 15, 2022

Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19.

Journal: Blood advances

Published: November 02, 2020